Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Alternative seafood startup Aqua Cultured Foods reels in $5.5M

From TechCrunch

By Christine Hall

April 6, 2023

Alternative seafood startup Aqua Cultured Foods reels in $5.5M

Alternative seafood startup Aqua Cultured Foods reels in $5.5M

Venture capital investors focused on food tech are calling 2023 the year when alternative seafood startups will make notable strides. Meanwhile, investors expect 40 investments to be made in this sector this year, up from 36 in 2022, according to the Good Food Institute’s annual investor report.

Within the past year, TechCrunch reported on a number of those investments into startups producing alternatives to traditional seafood. For example, one of the biggest venture capital investments into alternative seafood in 2022 went into Wildtype, which raised $100 million in a Series B round for its cultured salmon product. Meanwhile, New School Foods, Plantish, Bluu Seafood and the ISH Company also announced funding.

Today, Chicago-based Aqua Cultured Foods is adding itself to that list, announcing $5.5 million in seed funding to bring its pipeline of cultivated seafood alternatives to market.

Prior to starting the company, co-founder and CEO Anne Palermo was in finance, but always had an interest in health and wellness, so when the opportunity presented itself, she decided to go back to school to learn about product development and science.

Plant-based seafood startup the ISH Company rides new funding wave toward pipeline commercializatio

Aqua Cultured Foods alternative seafood dumpling

“Shrimp” dumpling. Image Credits: Aqua Cultured Foods

Following that, she started her first health snack company that leveraged proprietary formulations of a high protein snack through the use of protein isolates.

“It was really during the development of that product in particular that I got into the alternative protein set scene because it helped me to understand that there are a lot of alternative proteins that are not highly refined and do not come from animals,” Palermo said.

After learning about the microbial fermentation process for making food, Palermo decided to focus on seafood, explaining that “it is the most unstable supply chain of any animal protein,” due to things like the rise of the middle class and the increase in demand because of population growth in regions like China and Southeast Asia where seafood is the No. 1 protein consumed per capita.

However, overfishing and climate change is depleting the supply of fish, and “after really seeing and identifying what’s going on, I knew that we had to come up with a really fantastic product that could meet the look, texture, nutrition and commercial scale be able to eat it and to make the maximum global impact,” Palermo said.

Aqua Cultured Foods is creating whole-muscle cut seafood alternatives, including calamari, shrimp, scallops and filets of tuna and whitefish. The company also produces minced “seafood” fillings for applications like dumplings, ravioli and sushi rolls.

“Just texturally speaking, there’s nothing like it,” Palermo said. “It is nearly indistinguishable from tuna when it is inside of a maki roll. It is nearly indistinguishable from scallops. The products are currently optimized to be raw, and the texture is just so beautiful and silky. It’s quite an accomplishment.”

Palermo was mum on exactly how the technology worked, but did say the company was using proprietary mycoprotein (fungi) fermentation processes that don’t include any animal inputs, genetic altering or modification. She also said this process yields food with a lower price point to narrow the gap in price parity with traditional seafood.

“Aqua created novel processes and methods of production based on technologies and products that have existed for thousands of years, so we don’t have the same regulatory hurdles as other types of technologies have,” Palermo said. “They are already generally recognized as safe by the FDA. It’s part of the reason that we’re able to have such an accelerated market and be able to have so many really fantastic tastings.”

Aqua’s new investment was led by Stray Dog Capital and included H Ventures, Aztec Capital Management and Amplifica Capital, which joined existing investors Supply Change Capital, Big Idea Ventures, Hyde Park Angels, Aera VC, Kingfisher Capital and Swiss Pampa. The round also included a strategic investment from Asian food manufacturer and distributor CJ CheilJedang. In total, Aqua has raised just over $8 million, Palermo said.

New School Foods’ filet looks and tastes like salmon, but it’s actually plants

Brittany Chibe, Aqua’s co-founder and chief growth officer, has been in the food industry for over a decade and said the new funding will enable the company to begin manufacturing its first products by early summer. That will include tuna, scallops and ground shrimp.

The company recently acquired a 5,000-square-foot food-grade facility in Chicago, almost nearly built out, for its pilot facility. Palermo expects Aqua to be able to grow between 5,000 and 10,000 pounds of product in a 450-square-foot space.

“What that does is open us up to have decentralized manufacturing,” Palermo said. “When we eventually do move into new markets, for example, Asia, we’re going to be able to have a grow facility in Asia and we won’t have to ship products from the U.S. That’s a big area where we differentiate as well as just the inherent scalability of our products.”

Aqua will also use the investment in hiring additional employees and expanding its roster of restaurant and foodservice outlets for product introductions this year.

Chibe said the company sees “a path to quickly reach commercial scale,” and will respond to inbound interest from chefs with some initial pop-up shops to see how it goes.

“We’re not really sure what demand looks like, so if we can dedicate one weekend to specific restaurants, we will know about how much of it they’re going to sell,” Chibe said. “Then we can produce it ahead of time to get exactly what they need.”

4 investors discuss the next big wave for alternative seafood startups

Alternative seafood startup Aqua Cultured Foods reels in $5.5M by Christine Hall originally published on TechCrunch

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

Bluu Seafood reels in $17.5M to bring cultivated fish products to market

Bluu Seafood reels in $17.5M to bring cultivated fish products to market

Bluu Seafood, a German company creating cultivated (i.e. “lab-grown”) fish products, today announced it has raised €16 million ($17.5 million) in a Series A round of funding. Founded out of Berlin in 2020 originally as Bluu Biosciences, Bluu Seafood starts with a “one-time” fish biopsy — which, it says, doesn’t require killing any fish — […]

Jun 28, 2023

VCs remain confident alternative protein has a real future despite public-market woes

VCs remain confident alternative protein has a real future despite public-market woes

To get the pulse of what’s germinating in this fast rising industry, TechCrunch+ surveyed five alternative protein investors, and they had a lot to say on the subject.

Jun 12, 2023

Brevel sprouts $18.5M to develop microalgae-based alternative proteins

Brevel sprouts $18.5M to develop microalgae-based alternative proteins

Brevel developed a proprietary technology that combines fermentation and light to make a protein from microalgae that is sold to food companies as a powder for use in plant-based products.

Jul 25, 2023

Planet A Foods whips up more capital to take its cocoa-free chocolate global

Planet A Foods whips up more capital to take its cocoa-free chocolate global

Planet A Foods uses fermentation technology to turn all-natural, locally-sourcedningredients, for example, oats and sunflower seeds, into its cocoa-freenchocolate brand, ChoViva.

Feb 1, 2024

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

Bluu Seafood reels in $17.5M to bring cultivated fish products to market

Bluu Seafood reels in $17.5M to bring cultivated fish products to market

Bluu Seafood, a German company creating cultivated (i.e. “lab-grown”) fish products, today announced it has raised €16 million ($17.5 million) in a Series A round of funding. Founded out of Berlin in 2020 originally as Bluu Biosciences, Bluu Seafood starts with a “one-time” fish biopsy — which, it says, doesn’t require killing any fish — […]

Jun 28, 2023

VCs remain confident alternative protein has a real future despite public-market woes

VCs remain confident alternative protein has a real future despite public-market woes

To get the pulse of what’s germinating in this fast rising industry, TechCrunch+ surveyed five alternative protein investors, and they had a lot to say on the subject.

Jun 12, 2023

Brevel sprouts $18.5M to develop microalgae-based alternative proteins

Brevel sprouts $18.5M to develop microalgae-based alternative proteins

Brevel developed a proprietary technology that combines fermentation and light to make a protein from microalgae that is sold to food companies as a powder for use in plant-based products.

Jul 25, 2023

Planet A Foods whips up more capital to take its cocoa-free chocolate global

Planet A Foods whips up more capital to take its cocoa-free chocolate global

Planet A Foods uses fermentation technology to turn all-natural, locally-sourcedningredients, for example, oats and sunflower seeds, into its cocoa-freenchocolate brand, ChoViva.

Feb 1, 2024